Compare Anza Therapeutics vs Direct Therapeutics
Customers evaluate the quality of Anza Therapeutics's products using the following success metrics.
Overview
Anza Therapeutics is based in United States
Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.
Direct Therapeutics is based in United States
Direct Therapeutics is a development-stage pharmaceutical company uses its Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. The company's products are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate the penetration of the drug throughout tumor tissue and into tumor cells.
Demo Video
Leadership
David Cook (President)
Edward E. Luck (Chief Executive Officer, President)
Investors
Sofinnova Partners and Kleiner Perkins Caufield & Byers
Small Business Innovation Research Awards, Loeb Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Anza Therapeutics has not claimed their profile.
Work for Anza Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Anza Therapeutics?
Claim your profile now.
Information not available because Direct Therapeutics has not claimed their profile.
Work for Direct Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Direct Therapeutics?
Claim your profile now.